Key result
Technology-assisted collaborative care yields ~67% depression response at 12 weeks in preliminary study.
Why the study?
The comorbidity of depression with physical chronic diseases such as diabetes and/or high blood pressure is usually not considered in clinical guidelines.
Does a technology-assisted collaborative care program improve depression in patients with diabetes and/or high blood pressure?
Does a technology-assisted collaborative care program improve depression in patients with diabetes and/or high blood pressure?
A technology-assisted collaborative care program is partially feasible and potentially efficacious for managing depression in primary care patients with diabetes and/or hypertension.
The comorbidity of depression with physical chronic diseases is usually not considered in clinical guidelines. This study evaluated the feasibility of a technology-assisted collaborative care (TCC) program for depression in people with diabetes and/or high blood pressure (DM/HBP) attending a primary health care (PHC) facility in Santiago, Chile. Twenty people diagnosed with DM/HBP having a Patient Health Questionnaire-9 score ≥ 15 points were recruited. The TCC program consisted of a face-to-face, computer-assisted psychosocial intervention (CPI, five biweekly sessions), telephone monitoring (TM), and a mobile phone application for behavioral activation (CONEMO). Assessments of depressive symptoms and other health-related outcomes were made. Thirteen patients completed the CAPI, 12 received TM, and none tried CONEMO. The TCC program was potentially efficacious in treating depression, with two-thirds of participants achieving response to depression treatment 12 weeks after baseline. Decreases were observed in depressive symptoms and healthcare visits and increases in mental health-related quality of life and adherence to treatment. Patients perceived the CPI as acceptable. The TCC program was partially feasible and potentially efficacious for managing depression in people with DM/HBP. These data are valuable inputs for a future randomized clinical trial.
No takes yet. Share an insight, caveat, or question.
Martínez et al. (2021) studied Depression with diabetes and/or high blood pressure (n=20). Technology-assisted collaborative care (TCC) program was evaluated on Response to depression treatment 12 weeks after baseline. A technology-assisted collaborative care program was partially feasible and potentially efficacious, with two-thirds of participants achieving response to depression treatment at 12 weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: